Fed. Circ. Upholds Life Tech Injunction In Cell Patent Row

Law360, New York (January 9, 2012, 3:32 PM EST) -- The Federal Circuit on Monday rejected a bid by Life Technologies Corp. to overturn an injunction against the company in a patent infringement suit brought by Celsis In Vitro Inc. over methods used in the preparation of liver cells.

The appeals court rejected LTC's arguments that the district court had erred in ordering the biotechnology company to stop infringing Celsis' patented LiverPool cell development methodology in LTC's own in vitro drug metabolism processes, saying that the lower court was right to determine that Celsis would likely...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.